General
Preferred name
WARFARIN SODIUM
Synonyms
Warfarinum natricum ()
Coumadin ()
Marevan ()
Aldocumar ()
Apo-warfarin ()
Athrombin ()
Panwarfin ()
Zoocoumarin sodium salt ()
Prothromadin ()
Warfarin sodium salt ()
Jantoven ()
Sodium warfarin ()
P&D ID
PD002949
CAS
129-06-6
5543-79-3
36508-91-5
12795-55-0
Tags
natural product
drug
available
Drug Status
approved
Max Phase
Phase 4
Drug indication
Anticoagulant
First approval
1954
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Warfarin is an anticoagulant applicated in the prevention of thrombosis and thromboembolism, the formation of blood clots in the blood vessels and their migration elsewhere in the body. Warfarin was approved for use as a medication in 1954, and has remained popular ever since
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
5
BOC Sciences Bioactive Compounds
ChEMBL Approved Drugs
ChEMBL Drugs
NIH Clinical Collections (NCC)
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
23
Molecular Weight
330.09
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
0
Rotatable Bonds
4
Ring Count
3
Aromatic Ring Count
3
cLogP
-0.02
TPSA
70.34
Fraction CSP3
0.16
Chiral centers
1.0
Largest ring
6.0
QED
0.5
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Metabolism
Target
VKOR complex subunit 1
MOA
Vitamin inhibitor
Solubility
Soluble in DMSO
Source data
